Pluri shares rise 10.22% intraday after appointing Alejandro Weinstein as chairman and securing $2.5M investment.

Pluri surged 10.22% intraday following the announcement of Alejandro Weinstein’s appointment as Chairman, backed by a $2.5 million private placement. Weinstein, a seasoned biotech investor with a track record of value creation (including a $2.9 billion exit), will increase his ownership to 30% through the purchase of 625,000 shares and warrants. The leadership transition, alongside the capital raise, signals renewed focus on unlocking the company’s asset value and accelerating commercialization. Outgoing Chairman Zami Aberman’s transition to Vice Chairman further underscores strategic continuity. The move reflects investor confidence in Weinstein’s expertise to drive growth in regenerative medicine, foodtech, and agtech, aligning with Pluri’s long-term value proposition.